Observant’s Oncology Market Research Practice

Cancer is a leading cause of death and disability worldwide. According to the American Cancer Society, the lifetime risk of developing cancer is 45% for males and 38% for women in the United States. Cancers of the lung, colon, breast and stomach are among the top 10 causes of death in many countries. Accordingly, the cancer pharmaceutical marketplace is also experiencing explosive growth as drug manufacturers recognize this as a priority in their strategic plans.

Sophisticated oncology market research is more critical than ever to understand the impact of, and opportunity for, new therapies in this area. Delivering impactful oncology market insights requires both the ability to leverage creative and unique research methodologies, and an in-depth understanding of this dynamic therapeutic area.

Oncology is undergoing a number of significant market changes which impact the focus and execution of market research, including the rise of biologic therapies, a greater role for maintenance therapies, and an emerging cost-consciousness among oncologists.

Observant LLC brings an understanding of such trends across multiple cancers (e.g., breast cancer, non-small cell lung cancer, colorectal cancer, renal cell carcinoma, soft tissue and bone sarcomas), together with the principals’ social science and marketing research methodological expertise to provide impactful strategic insight.

Oncology market research examples of high value to our clients

Our Genetic Engineering News paper on physicians’ perceptions of therapeutic vaccines

For more information about Observant LLC’s oncology market research expertise, or to discuss potential research engagements, please contact:  oncology@observant.biz